2026

Articles
Title
iX Biopharma: Broker Issues Rare 5X Target. How Did It Arrive At That?
YANGZIJIANG MARITIME: Why This Spin-Off Stock Rose 20+% After Phillip and DBS Initiated Coverage
ANALYSTS SAY: Buy, Sell, Hold (10 Apr)
NAM CHEONG: 70% of Fleet on Long-Term Charters, Analyst Target Prices At 10-11x PE
ANALYSTS SAY: Buy, Sell, Hold (9 Apr)
The Oiltek Upgrade: How Two Analysts Justify S$2.70+ Target Prices
ANALYSTS SAY: Buy, Sell, Hold (8 Apr)
Is Koh Brothers Eco A Cheap Way to Own Hot Stock Oiltek?
ANALYSTS SAY: Buy, Sell, Hold (7 Apr)
At 3.1x P/E, Isn't This Company A Value Play in S'pore Construction Boom?